Exudative Vitreoretinopathy 1 C1851402
A hereditary eye disorder causing abnormal blood vessel growth in the retina, potentially leading to vision loss. Management includes laser therapy and surgery.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Photopsia
Generalized symptoms
(ophthalmologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Decreased visual acuity
(ophthalmologic)Metamorphopsia
(ophthalmologic)Night blindness
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Anti-VEGF intravitreal therapy
Intravitreal injections of anti-vascular endothelial growth factor agents to reduce retinal neovascularization and vascular permeability, potentially slowing disease progression and reducing exudation.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Vitrectomy with membrane peeling
Surgical removal of vitreous hemorrhage, epiretinal membranes, or tractional components causing retinal detachment. Often combined with laser photocoagulation.
Additional treatment options
Laser photocoagulation
Argon or diode laser treatment to ablate ischemic retinal areas and abnormal neovascularization, reducing risk of hemorrhage and tractional complications.
procedureSystematic ophthalmologic monitoring
Regular comprehensive eye examinations including imaging with OCT, fluorescein angiography, and widefield retinal imaging to detect disease progression and treatment response.
monitoringActivity modifications and eye protection
Avoidance of activities that may increase retinal hemorrhage risk such as contact sports. Protection of eyes from trauma and management of systemic conditions like diabetes that may worsen retinal disease.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Exudative Vitreoretinopathy 1 C1851402?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Exudative Vitreoretinopathy 1 C1851402. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy